FDA Investigator Syeda N Mahazabin

Syeda N Mahazabin has conducted inspections on 26 sites in 2 countries as of 20 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
26
Last Inspection Date:
20 May 2024
Investigator Role:
FDA Investigator
Redica ID:
100008588
Countries of Inspections:
United States of America, China
FDA Investigators that have inspected at least one site in common with Syeda N Mahazabin:
Alice S Tsao, Amatul H Marium, Anastasia M Shields, Anita R Michael, Ankur C Patel, Ann M Stewart, Anthony J Donato, Aziz A Mamur, Benton M Ketron, Bijoy Panicker, Brandy N Lepage, Bruce G Cooper, Carolyn J Cook, Charisse K Green, Christina K Theodorou, Christopher S Fields, Cynthia A Palmer, Dana A Razzano, Daniel L Aisen, Daniel R Tammariello, David A Carlson, David M Mcnew, David R Delucia, Demitria J Argiropoulos, Demitria J Xiradakis, Devon Jenkins, Dr. Robert C Horan, MD, Edwin Melendez, Erica B Raphael, Evan Tong, Frederick F Razzaghi, Gam S Zamil, Geoffrey K Wong, George C Amedro, Gladys B Casper, Hala L Selby, Harry J Brewer, Helen B Ricalde, Heriberto Negron Rivera, Iram R Hassan, PhD, Jacqueline S Warner, James A Liubicich, James D Bridges, James M Mason, James M Odonnell, James R Birkenstamm, Jay T Wong, Jeanette L Mcginnis, Joanne M Schlossin, John A Podsadowski, Johnna L Bleem, Jose Ohernandez Guzman, Joseph J Vannelli, Joy P Matthias, Juliana M Badalucco, Julianne C Mccullough, Junho Pak, Karen F Tomaziefski, Karen L Kosar, Katelyn Astaub Zamperini, Kendra L Brooks, Kenneth G Klobus, Kevin A Gonzalez, Kim M Downing, Kimberley A Ricketts, Ko U Min, Kwong P Lee, Lauren E Blaser, Lawrence Harmon, Jr, Lawrence W Farina, Linda M Sacco, Loretta Nemchik, Margaret E Sarles, Margaret M Sands, Maria A Reed, Maria Estrella, Marie Elena C Puleo, Marlene L Davis, Matthew A Spataro, Matthew D Schnittker, Meredith P Soehl, Investigator, Michael A Charles, Michael Levin, Michael W Burd, Mindy M Chou, Monika Borkowska, Nancy M Espinal, Neil J Bonzagni, PhD MPH, Nicholas A Violand, Nicholas C Mendiola, Niketa Patel, Nina Yang, Paige R Mccoy, Parul M Patel, Patricia A Clark, Patrick C Klotzbuecher, Paul E Stein, Paul L Bellamy, Paul Mouris, Perry T Nichols, Rachael A Moliver, Richard K Glabach, Robert C Steyert, Rochelle K Kimmel, Rose Ljean Mary, Ruben C Quintana, Russ E Davis, Russell J Glapion, Samina S Khan, Samuel T Walker, Sasha M Latonis, Satheesh Thomas, Sayyem H Akbar, Shari L Kahn, Shirley J Berryman, Simone E Pitts, Sony Mathews, Susan F Laska, MS, Tammy S Notto, Tanya R Syffrard, Thomas J Mooney, Thomas P Hansen, Todd J Maushart, Tonia F Bernard, Tracey L Harris, Uduak M Inokon, Vanessa M Williams, Victoria Spivak, Vivin George, Vlada Matusovsky, William J Leonard, Xiaoping Guan, Yvesna C Blaise, Zhongren Wu, Zi Qiang Gu

Syeda N Mahazabin's Documents

Publish Date Document Type Title
December, 2021 FDA 483 Aurora Labs, LLC - Form 483, 2021-12-03
April, 2022 EIR iuvo BioScience Operations, LLC - EIR, 2022-04-15
March, 2022 FDA 483 CooperSurgical, Inc. - Form 483, 2022-03-04
March, 2023 FDA 483 Cetylite Industries, Inc. - Form 483, 2023-03-02
March, 2022 EIR CooperSurgical, Inc. - EIR, 2022-03-18
December, 2023 FDA 483 Velocity Pharma LLC - Form 483, 2023-12-14
November, 2022 FDA 483 Pharbest Pharmaceuticals, Inc. - Form 483, 2022-11-10
February, 2024 FDA 483 AIRGAS USA, LLC - Form 483, 2024-02-23
March, 2023 FDA 483 Response Cetylite Industries, Inc. - Form 483R, 2023-03-02
January, 2024 FDA 483 Radienz Living,LLC - Form 483, 2024-01-11
October, 2022 FDA 483 MANA PRODUCTS, INC. - Form 483, 2022-10-17
March, 2024 FDA 483 Cosco Enterprises, Inc - Form 483, 2024-03-26
February, 2024 FDA 483 PEDIFIX, INC. - Form 483, 2024-02-12
June, 2022 FDA 483 GC HANFORD MFG CO - Form 483, 2022-06-17
October, 2021 FDA 483 Unither Manufacturing LLC - Form 483, 2021-10-15
July, 2022 FDA 483 Brittonfield Laboratories - Form 483, 2022-07-08
June, 2023 FDA 483 InvaTech Pharma Solutions LLC - Form 483, 2023-06-09
December, 2022 FDA 483 Health Pharma USA LLC - Form 483, 2022-12-20
March, 2022 FDA 483 Response CooperSurgical, Inc. - Form 483R, 2022-03-21
September, 2023 FDA 483 Ultra Seal Corporation - Form 483, 2023-09-20
September, 2022 FDA 483 Athenex Pharma Solutions, LLC - Form 483, 2022-09-16
October, 2021 EIR Unither Manufacturing LLC - EIR, 2021-10-15
July, 2024 FDA 483 The Skin Atelier, Inc. dba Skinprint - Form 483, 2024-07-26

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more